Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based Therapy

Am J Med. 2024 Jul;137(7):589-591. doi: 10.1016/j.amjmed.2024.02.013. Epub 2024 Feb 22.

Authors

Omar Khan¹, Sonam Prakash¹, Alfred Chung², Sandy W Wong², Vanessa E Kennedy³

Affiliations

¹ Department of Laboratory Medicine, University of California San Francisco Medical Center, San Francisco.
² Division of Hematology and Oncology, Department of Medicine, University of California San Francisco Medical Center, San Francisco.
³ Division of Hematology and Oncology, Department of Medicine, University of California San Francisco Medical Center, San Francisco. Electronic address: [email protected].

PMID: 38401677
DOI: 10.1016/j.amjmed.2024.02.013

No abstract available

Publication types

Case Reports

MeSH terms

Anemia / drug therapy
Anemia / etiology
Antibodies, Monoclonal* / therapeutic use
Humans
Paraproteinemias* / complications
Paraproteinemias* / drug therapy
Red-Cell Aplasia, Pure* / drug therapy

Substances

Antibodies, Monoclonal
daratumumab